Molecular Pathways and Animal Models of Cardiomyopathies.
In: Advances in experimental medicine and biology, Jg. 1441 (2024), S. 991-1019
academicJournal
Zugriff:
Cardiomyopathies are a heterogeneous group of disorders of the heart muscle that ultimately result in congestive heart failure. Rapid progress in genetics, molecular and cellular biology with breakthrough innovative genetic-engineering techniques, such as next-generation sequencing and multiomics platforms, stem cell reprogramming, as well as novel groundbreaking gene-editing systems over the past 25 years has greatly improved the understanding of pathogenic signaling pathways in inherited cardiomyopathies. This chapter will focus on intracellular and intercellular molecular signaling pathways that are activated by a genetic insult in cardiomyocytes to maintain tissue and organ level regulation and resultant cardiac remodeling in certain forms of cardiomyopathies. In addition, animal models of different clinical forms of human cardiomyopathies with their summaries of triggered key molecules and signaling pathways will be described.
(© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.)
Titel: |
Molecular Pathways and Animal Models of Cardiomyopathies.
|
---|---|
Autor/in / Beteiligte Person: | Orgil, BO ; Purevjav, E |
Zeitschrift: | Advances in experimental medicine and biology, Jg. 1441 (2024), S. 991-1019 |
Veröffentlichung: | 1998- : New York : Kluwer Academic/Plenum Publishers ; <i>Original Publication</i>: New York, Plenum Press., 2024 |
Medientyp: | academicJournal |
ISSN: | 0065-2598 (print) |
DOI: | 10.1007/978-3-031-44087-8_64 |
Schlagwort: |
|
Sonstiges: |
|